Clinical importance of serum and urine free kappa & lambda light chain concentrations in primary (AL) amyloidosis

被引：0
|
作者：
Tang, L [1 ]
Wolfenbarger, D [1 ]
Williams, T [1 ]
Weiss, D [1 ]
Solomon, A [1 ]
机构：
[1] Univ Tennessee, Grad Sch Med, Human Immunol & Canc Program, Knoxville, TN 37920 USA
来源：
AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS | 2001年 / 8卷
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：86 / 87
页数：2
相关论文
共 50 条
  • [41] Treatment of Immunoglobulin Light Chain (Primary or AL) Amyloidosis
    Gertz, Morie A.
    Buadi, Francis K.
    Hayman, Suzanne R.
    ONCOLOGY-NEW YORK, 2011, 25 (07): : 620 - 626
  • [42] Role of nephelometry-based detection of serum free light chain Kappa/Lambda in diagnosis of multiple myeloma
    Zarablouri, F.
    Popov, J.
    Montana, L.
    Sferruzza, A.
    Naides, S. J.
    CLINICAL CHEMISTRY, 2007, 53 (06) : A149 - A149
  • [43] Analysis of immunoglobulin light chains in primary amyloidosis - Direct on-line assay for amyloidogenic kappa and lambda light chains directly from serum
    Naylor, S
    Abraham, RS
    Bradwell, AR
    Fonseca, R
    Katzmann, J
    Kyle, RA
    Bergen, HR
    AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS, 2001, 8 : 86 - 86
  • [44] Utility of serum free light chain measurements for assessing response following autologous stem cell transplantation for primary amyloidosis (AL)
    Kyle, RA
    Gertz, MA
    Katzmann, JA
    Clark, RJ
    Abraham, RS
    AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS, 2001, 8 : 71 - 72
  • [45] Clinical Utility of The Serum Free Light Chain Assay in Primary Care
    Lodwick, C.
    Pratt, G.
    Drayson, M.
    Lester, W.
    BRITISH JOURNAL OF HAEMATOLOGY, 2019, 185 : 15 - 15
  • [46] Hepatomegaly and cholestasis as primary clinical manifestations of an AL-kappa amyloidosis
    Mohr, A
    Miehlke, S
    Klauck, S
    Röcken, C
    Malfertheiner, P
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 1999, 11 (08) : 921 - 925
  • [47] Prevalence and clinical significance of abnormal serum kappa/lambda light chain ratio in patients with chronic kidney disease
    Niewmierzycka, Aneta
    Kurman, Mariusz
    Lesniak, Mikolaj
    Winiarska, Agata
    Pawlowska, Anna
    POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ-POLISH ARCHIVES OF INTERNAL MEDICINE, 2015, 125 (7-8): : 532 - 537
  • [48] ADULT FANCONI SYNDROME IN PRIMARY AMYLOIDOSIS WITH LAMBDA LIGHT-CHAIN PROTEINURIA
    RIKITAKE, O
    SAKEMI, T
    YOSHIKAWA, Y
    NAGANO, Y
    WATANABE, T
    JAPANESE JOURNAL OF MEDICINE, 1989, 28 (04) : 523 - 526
  • [49] Lambda II immunoglobulin light chain protein in primary localized rectal amyloidosis
    Zaky, Ziad S.
    Liepnieks, Juris J.
    Rex, Douglas K.
    Cummings, Oscar W.
    Benson, Merrill D.
    AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS, 2007, 14 (04): : 299 - 304
  • [50] Primary AL (κ-light chain) amyloidosis manifesting as peripheral neuropathy in a young male without increase in serum and urine immunoglobulin load:: a diagnostic challenge
    Sarkar, C
    Sharma, MC
    Nayak, A
    Ralte, AM
    Gupta, V
    Singh, S
    Behari, M
    CLINICAL NEUROPATHOLOGY, 2005, 24 (03) : 118 - 125
12345